Custom Manufacturing, Project Outsourcing, your Trusted Partner from China
The efficacy of targeted therapies in modern medicine hinges on the precise design and synthesis of molecules that interact specifically with disease-driving biological targets. ABT-199 (CAS 1257044-40-8), a potent inhibitor of the Bcl-2 protein, is a prime example of such molecular engineering. Understanding its chemical structure, molecular formula (C45H50ClN7O7S), and molecular weight (868.44) is fundamental for both its application in research and its potential as a pharmaceutical ingredient.
The complex molecular architecture of ABT-199 is tailored to fit snugly into the binding pocket of the Bcl-2 protein, disrupting its interaction with pro-apoptotic proteins. This intricate design ensures high selectivity for Bcl-2 over other related anti-apoptotic proteins, a critical factor in minimizing off-target effects and maximizing therapeutic benefit. The presence of specific functional groups within the molecule dictates its binding affinity, solubility, and overall pharmacokinetic properties.
For manufacturers and chemists involved in the synthesis of ABT-199, achieving high purity and yield requires sophisticated synthetic strategies. The multi-step synthesis often involves complex heterocyclic chemistry and careful control of reaction conditions to assemble the various structural components. The resulting product, typically a yellow solid, must meet stringent quality standards to be suitable for pharmaceutical research and development.
When procuring ABT-199, buyers should pay close attention to the details provided by suppliers, including purity assays (e.g., HPLC), structural confirmation (e.g., NMR, Mass Spectrometry), and any available synthesis route information. This diligence ensures that the ABT-199 obtained is indeed the correct compound with the required quality for its intended application, whether it's for in vitro studies on apoptosis, in vivo efficacy testing in animal models, or as an intermediate for further drug formulation.
As the demand for targeted cancer therapies continues to grow, the importance of molecules like ABT-199 and the expertise in their chemical synthesis and reliable supply will only increase. Collaborating with reputable manufacturers who possess the chemical acumen to produce ABT-199 consistently and efficiently is key to advancing pharmaceutical innovation in the field of oncology.
Manufacturing Facilities
Professional Export Experience
to Global Customers
1. 20 years of R&D, manufacturing and sales experience, serving customers in 60 countries and regions around the world;
2. Own R&D laboratory, pilot platform and large-scale production workshop, which can meet the audit requirements of global customers;
3. We can satisfy customers' perfect transition from small scale lab requirements (gram level) to commercialization requirements (hundred tons level).
A: We don't have Minimum Order Quantity, exact quantity should be provided before quotation for us to calculate the exact cost.
A: We don't provide free samples due to lots of request and expensive international courier's cost, we can deduct the sample charge after commercial order placed.
A: Our payment terms: Small or sample order: T/T IN ADVANCE. Commercial order: First order should be by T/T IN ADVANCE or L/C at sight, and following orders T/T 30~90days is acceptable subject to approval of credit application.
